Skip to main content
. 2010 Apr 20;7(4):e1000267. doi: 10.1371/journal.pmed.1000267

Table 7. Multivariable meta-regression analysis for different variables as indicated and described in the Methods section.

Potential Explanation Factor Variable Resection Rate Exploration Rate CR PR SD PD Toxicity Morbidity Mortality
Institution 16.7% (17.4%) 13.3% (15.0%) 30.2% (31.9%) 20.9% (16.7%) 27.2% (10.7%) 12.8% (24.9%) 34.8% (35.2%) 20.8% (14.3%) 22.5% (19.6%)
Study design 1.2% (2.9%) 0.6% (1.6%) 3.1% (1.0%) 10.7% (4.0%) 4.1% (1.8%) 3.6% (6.9%) 3.8% (4.6%) 8.7% (2.0%) 2.3% (1.6%)
Chemotherapy 2.1% (3.1%) 0.8% (1.6%) 0.6% (8.1%) 6.0% (7.2%) 1.6% (0.8%) 0.2% (0.4%) 10.4% (2.4%) 0.1% (0.5%) 3.1% (6.8%)
Mean year of study interval (decades) 2.0% (1.9%) 1.1% (0.2%) 0.2% (2.0%) 0.6% (6.7%) 2.3% (1.0%) 0.9% (7.0%) 2.2% (1.5%) 3.2% (2.0%) 10.4% (10.6%)
Mean patient age (5-y intervals) 1.1% (1.1%) 1.2% (0.6%) 2.7% (1.1%) 3.4% (3.4%) 1.5% (1.8%) 1.4% (1.7%) 3.5% (2.6%) 9.9% (4.1%) 9.9% (4.6%)
Response evaluation criteria 1.5% (3.4%) 2.7% (3.6%) 2.4% (0.1%) 2.6% (0.3%)
Resectability 14.0% (9.0%) 25.5% (10.5%) 1.0% (0.9%) 0.0% (2.6%) 4.1% (0.9%) 1.1% (8.1%) 0.3% (0.2%) 2.2% (4.9%) 0.6% (0.2%)
Resectability evaluation criteria 0.1% (0.7%) 1.4% (0.7%)

The fraction of explained variance is given in %. Values in parentheses represent the fraction of explained variance in % from univariable analysis.

CR, complete response; PD, progressive disease; PR, partial response; SD, stable disease.